24 Sep 2020

Almac Group Launches Biologics Testing Solutions

JPG 70 kB

Almac Sciences, a member of the Almac Group, has announced the expansion of its existing suite of analytical solutions to include biologics testing. 

This new offering follows the announcement of the company’s expansion of its Irish laboratory in 2019 and from which Almac Sciences now provides a comprehensive range of flexible pharmaceutical testing services to support clients’ drug development programs adhering to industry regulations including FDA, EMA and PMDA, under GMP standards

Almac’s new services include GMP lot release and stability testing to support clients’ drug substance and drug product programs for both novel biologics and biosimilars; fit-for-purpose analytical method development / phase-appropriate method validation; raw material testing for microbial and mammalian expression systems that comply with pharmacopeial requirements and clients’ specifications. 

Content provided by our supplier

Almac Group

  • GB
  • 2015
    On CPHI since
  • 4
  • 5000+
Company types
Contract Service
Packaging supplier/manufacturer
Primary activities
Analytical Services
API Producer
Chemical Development
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Fine Chemicals Company
Intermediates Manufacturer
Laboratory Services
Packaging & drug delivery
Supply Chain

Other Content from Almac Group (16)